K
Kimon Stamatelopoulos
Researcher at National and Kapodistrian University of Athens
Publications - 251
Citations - 6993
Kimon Stamatelopoulos is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Blood pressure & Medicine. The author has an hindex of 39, co-authored 206 publications receiving 5470 citations. Previous affiliations of Kimon Stamatelopoulos include Alexandra Hospital & Newcastle University.
Papers
More filters
Journal ArticleDOI
Plasma levels of stromal cell-derived factor-1 in patients with coronary artery disease: Effect of clinical presentation and cardiovascular risk factors
Konstantinos Stellos,Madlen Ruf,Kateryna Sopova,Antonios Kilias,Angela Rahmann,Kimon Stamatelopoulos,Rezo Jorbenadze,Tobias Geisler,Meinrad Gawaz,Boris Bigalke,Boris Bigalke +10 more
TL;DR: Plasma SDF-1 was significantly decreased in ST-elevation myocardial infarction (STEMI) compared to stable angina pectoris (SAP) or to non-ST-e Elevation my cardiac infarctions (N STEMI) independent of cardiovascular therapy.
Journal ArticleDOI
Free androgen index as a predictor of blood pressure progression and accelerated vascular aging in menopause.
Georgios Georgiopoulos,Irene Lambrinoudaki,Fani Athanasouli,Eleni Armeni,Demetrios Rizos,Maria Kazani,Marianna Karamanou,Efstathios Manios,Areti Augoulea,Konstantinos Stellos,Christos Papamichael,Kimon Stamatelopoulos +11 more
TL;DR: In apparently healthy postmenopausal women, FAI could be a novel biomarker superior to total testosterone for accelerated vascular aging and hypertension status.
Journal ArticleDOI
Arterial stiffness but not intima-media thickness is increased in euthyroid patients with Hashimoto's thyroiditis: The effect of menopausal status.
Kimon Stamatelopoulos,Katerina Kyrkou,Elda Chrysochoou,Helen Karga,Sofia Chatzidou,Georgios Georgiopoulos,Stellios Georgiou,Konstantinos Xiromeritis,Christos Papamichael,Maria Alevizaki +9 more
TL;DR: HT is associated with increased PWV independent of arterial atheromatosis, indicating a direct impact of this disorder on arterial stiffening in postmenopausal women possibly due to their heavier cardiovascular risk profile.
Journal ArticleDOI
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis.
Alberto Aimo,Konstantinos Pateras,Kimon Stamatelopoulos,Antoni Bayes-Genis,Carlo Lombardi,Claudio Passino,Michele Emdin,Georgios Georgiopoulos,Georgios Georgiopoulos +8 more
TL;DR: Based on an indirect comparison, SGLT2i therapy is not associated with a significantly lower risk of CV death or HF hospitalization or CV death alone compared to sacubitril/valsartan or vericiguat, while dapagliflozin is superior to vericIGuat.
Journal ArticleDOI
Menopausal symptoms are associated with subclinical atherosclerosis in healthy recently postmenopausal women.
Irene Lambrinoudaki,Areti Augoulea,Eleni Armeni,Demetrios Rizos,Andreas Alexandrou,Maria Creatsa,Maria Kazani,Georgios Georgiopoulos,Alexandra Livada,Aimilia Exarchakou,Kimon Stamatelopoulos +10 more
TL;DR: Carotid IMT, a surrogate marker of subclinical atherosclerosis and cardiovascular risk, was found to be increased in women with vasomotor symptoms as compared to asymptomatic women, independent of cardiovascular risk factors or endogenous hormone levels.